引用本文:代 艳,李新叶,唐慧荷,孙会静,梁 亮,温志红.非HIV感染的免疫低下者肺孢子菌肺炎防治进展[J].中国临床新医学,2021,14(2):134-138.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 3482次   下载 1546 本文二维码信息
码上扫一扫!
分享到: 微信 更多
非HIV感染的免疫低下者肺孢子菌肺炎防治进展
代 艳,李新叶,唐慧荷,孙会静,梁 亮,温志红
530021 南宁,广西壮族自治区人民医院儿科(代 艳,李新叶,唐慧荷,温志红),药学部(孙会静),检验科(梁 亮)
摘要:
[摘要] 肺孢子菌肺炎(PCP)是由人耶氏肺孢子菌引起的呼吸系统严重机会感染。认识PCP在儿童移植受者和肿瘤患者中的危险因素和临床表现,了解其预防适应证和治疗方案,对促进早诊断和降低患病风险至关重要。考虑这一复杂的患者群体经常面临的具体挑战,该文对PCP防治进展进行综述。
关键词:  肺孢子菌肺炎  儿童  血液病  移植  肿瘤  免疫功能不全  预防  治疗
DOI:10.3969/j.issn.1674-3806.2021.02.04
分类号:R 563.1
基金项目:广西卫健委科研课题(编号:Z20170360)
Progress of the prevention and treatment of Pneumocystis pneumonia in non-HIV infected immunocompromised patients
DAI Yan, LI Xin-ye, TANG Hui-he, et al.
Department of Paediatrics, the People′s Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China
Abstract:
[Abstract] Pneumocystis pneumonia(PCP) is a severe opportunistic respiratory infection caused by human Pneumocystis jiroveci. Understanding the risk factors and clinical manifestations of PCP in pediatric transplant recipients and cancer patients, and understanding the indications for prevention and treatment regimens, are critical to promoting early diagnosis and reducing the risk of PCP. In view of the specific challenges that this complex patient population often face, we review the progress of the prevention and treatment of PCP in this paper.
Key words:  Pneumocystis pneumonia(PCP)  Children  Blood disease  Transplantation  Tumor  Immunodeficiency  Prevention  Treatment